1. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis;Crystal, R.G.; McElvaney, N.G.; Rosenfeld, M.A.; Chu, C.S.; Mastrangeli, A.; Hay, J.G.;Nature Genet,1994
2. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis;Caplen, N.J.; Alton, E.W.F.W.; Middleton, P.G.; Dorin, JR, Stevenson; BJ, Gao; X.;Nature Med,1995
3. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis;Porteous, D.J.; Dorin, JR, McLachlan; G, Davidson-Smith; H, Davidson; H, Stevenson; B.J.;Gene Therapy,1997
4. Gene therapy approaches for inherited and acquired lung diseases;Curiel, D.T.; Pilewski, J.M.; Abelda, S.M.;Am J Respir Cell Mol Biol,1996
5. Targeted vectors for gene therapy;Miller, N.; Vile, R.;FASEB J,1995